Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
公司代碼RDY
公司名稱Dr Reddy's Laboratories Ltd
上市日期Jan 01, 1986
CEOAghanian (Patrick)
員工數量27811
證券類型Depository Receipt
年結日Jan 01
公司地址8-2-337, Road No.3 Banjara Hills
城市HYDERABAD
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家India
郵編500-034
電話914049002900
網址https://www.drreddys.com/
公司代碼RDY
上市日期Jan 01, 1986
CEOAghanian (Patrick)